The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emir Deljkich
Imperative Care, Inc.
Study Director - Raul G Nogueira, MD
University of Pittsburgh
Principal Investigator - Reade A De Leacy, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - William J Mack, MD
University of Southern California
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Radiology of Huntsville
Huntsville, Alabama, United States
- Carondelet Neurological Institute St. Joseph'S Hospital
Tucson, Arizona, United States
- University of Southern California
Los Angeles, California, United States
- John Muir Health
Walnut Creek, California, United States
- Baptist Health
Jacksonville, Florida, United States
- University of Miami / Jackson Memorial Hospital
Miami, Florida, United States
- Tallahassee Neurological Clinic
Tallahassee, Florida, United States
- Tampa General Hospital / University of South Florida
Tampa, Florida, United States
- Grady Memorial Hospital / Emory University
Atlanta, Georgia, United States
- Ochsner Health
New Orleans, Louisiana, United States
- Spectrum Health
Grand Rapids, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Cooper University Health Care
Camden, New Jersey, United States
- the State University of New York at Buffalo
Buffalo, New York, United States
- Mount Sinai
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- Oklahoma University
Oklahoma City, Oklahoma, United States
- Lehigh Valley Hospital
Allentown, Pennsylvania, United States
- Upmc
Pittsburgh, Pennsylvania, United States
- University of Pennsylvania
Pittsburgh, Pennsylvania, United States
- Prisma Health - Upstate
Greenville, South Carolina, United States
- Erlanger Health System: Tennessee Interventional and Imaging Associates
Chattanooga, Tennessee, United States
- Semmes Murphey Foundation / Methodist University Hospital
Memphis, Tennessee, United States
- Baylor Scott and White Research Institute
Dallas, Texas, United States
- Valley Baptist Medical Center
Harlingen, Texas, United States
- the University of Texas Health Science Center at Houston // Memorial Hermann Health System
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2021
- Primary completion
- 28 May 2024
- Completion
- 28 May 2024
- Last update posted
- 8 Aug 2025
- Registered enrollment
- 328
- Registry id
- NCT04129125
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.